000 01199 a2200313 4500
005 20250517015922.0
264 0 _c20151103
008 201511s 0 0 eng d
022 _a1520-4383
024 7 _a10.1182/asheducation-2014.1.559
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMaude, Shannon L
245 0 0 _aChimeric antigen receptor T-cell therapy for ALL.
_h[electronic resource]
260 _bHematology. American Society of Hematology. Education Program
_cDec 2014
300 _a559-64 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntigens, CD19
_ximmunology
650 0 4 _aClinical Trials as Topic
650 0 4 _aHumans
650 0 4 _aImmunotherapy
650 0 4 _aPrecursor Cell Lymphoblastic Leukemia-Lymphoma
_ximmunology
650 0 4 _aReceptors, Antigen, T-Cell
_ximmunology
650 0 4 _aT-Lymphocytes
_ximmunology
650 0 4 _aTreatment Outcome
700 1 _aShpall, Elizabeth J
700 1 _aGrupp, Stephan A
773 0 _tHematology. American Society of Hematology. Education Program
_gvol. 2014
_gno. 1
_gp. 559-64
856 4 0 _uhttps://doi.org/10.1182/asheducation-2014.1.559
_zAvailable from publisher's website
999 _c24638041
_d24638041